Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.
More on the types of investments we make.
Here you can explore our current and past investments, filtered by issue area or investment type.
The Agtech Accelerator is a start-up incubator based in Research Triangle Park, NC focused on fostering entrepreneurship in agriculture, supported by a syndicate of investors, including ARCH Venture Partners, Flagship Ventures, Hatteras Venture Partners, Bayer CropScience, Syngenta Ventures, and others.
Press Release
The foundation invested in Amyris to support the development of new, low-cost technologies for manufacturing compounds to make semi-synthetic artemisinin that can be used in anti-malaria treatments.
Anacor Pharmaceuticals developed and commercialized novel therapeutics with its boron chemistry platform. The foundation partnered with the team to support development of preclinical drug candidates.
Press Release
Arsanis is focused on discovery and development of novel monoclonal antibodies (“mAbs”) to prevent and treat infectious disease. The foundation is working with Arsanis to develop a prophylactic mAb candidate targeting Stap aureus, a leading cause of neonatal sepsis which leads to approximately 345,000 annual deaths globally.
Press Release
Aspire Public Schools is a Charter Management Organization (CMO) and a top-ranked school system for low-income students.
Press Release
Atreca is a biotechnology company that employs its proprietary discovery platform to generate and develop therapeutics based on its ability to rapidly characterize the human adaptive immune response at the single cell level. The Atreca platform enables the high-throughput phylogenetic Read More
News Story
Aurobindo Pharma, along with Mylan Laboratories, received support from the foundation to expand the distribution of a single-pill HIV treatment containing dolutegravir to low- and middle-income populations at a low price.
Press Release
Avanti Finance Private Limited is a Non-Banking Financial Company and financial technology platform in India focused on enabling financial inclusion and sustainable livelihoods through improved access to affordable, livelihoods-purpose credit for unbanked and low-income populations across the country. The foundation Read More
Press Release
The foundation partnered with private and public organizations to make Jadelle®, an effective, long-acting, reversible contraceptive implant, available to more than 27 million women in the world’s poorest countries at a more than 50 percent price reduction.
Press Release
Beijing Bio-Institute Biological Products is devoted to the research, development, production, and supply of biological products.
Press Release